Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: efficacy and prognostic factors for response - Vaughan, E; Machta, J; Walker, M; Toumpanakis, C; Caplin, M; Navalkissoor, S (Br J Radiol, 2018)
(1091):